Table 2.

Brief summary of the main outcomes of the studies conducted in pregnant women with GDM.

	Pérez-Ferre et al. [13]	Pérez-Ferre et al. [14]	Homko et al. [15]	Homko et al. [16]	Dalfrà et al. [8]
Number of participants (interv./control)	49/48	49/48	32/25	40/40	88/115
Duration of monitoring (days ± SD; interv./control)	94 ± 26/94 ± 24	94 ± 26/94 ± 24	71 ± 40/69 ± 38	71 ± 39/67 ± 38	76 ± 25/75 ± 27
Subjects training (interv./control)	Internet and SMS/TSV	Internet and SMS/TSV	Website for recording glucose values/paper logbook	Website for recording glucose values/paper logbook	Glucobeep system/CE every 2 weeks
Clinical outcome (metabolic/QoL)	=/nv	=/+	=/+	=/nv	+/+
Behavioural outcome	nv	+	+	+	+
Care coordination outcome	+	+	nv	nv	nv

For more details about the clinical, behavioral, and care coordination outcomes, refer to Verhoeven et al. [9].

QoL: quality of life; SD: standard deviation; nv: not valued; SMS: short message service; TSV: traditional face-to-face visits; CE: clinical examinations.